Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Philip Morris outlook disappoints, shares dip

(Sharecast News) - Philip Morris International posted below-forecast numbers on Thursday, on the back of higher costs and weaker-than-expected sales of heated tobacco products. The US owner of Marlboro cigarettes reported a 0.5% decline in shipment volumes of cigarettes and heated tobacco units (HTUs) in the fourth quarter, to 185.1bn.

In contrast, total shipment volumes had risen 2.2% in the third quarter.

However, HTU shipments alone rose 6.1% to 34bn.

Net revenues jumped 11% on a reported basis, or 8.3% once adjusted, to $9bn.

But cost of sales increased by 8.4% over the year, driven primarily by higher manufacturing costs as tobacco leaf and energy prices rose.

Operating income fell 1.2% on a reported basis in the fourth quarter, to $2.9bn, with adjusted diluted earnings per share of $1.36, below forecasts for $1.45.

Looking to the current year, PMI said total cigarette, HTU and oral smoke-free product shipment volume growth was likely be flat to 1%.

A decision by the European Union to ban certain flavours of heated tobacco products was likely see 2bn units knocked off annual volumes, PMI warned.

Adjusted diluted earnings per share were forecast to come in between $6.32 and $6.44. Analysts had been looking for closer to $6.60 per share in 2024.

However, PMI stressed it remained on track to meet its long-term goal of becoming a smoke-free company, with smoke-free products accounting for 39.3% of total net revenues in the fourth quarter.

Jacek Olczak, chief executive, said: "We are pleased that smoke-free products reached nearly 40% of our total net revenues and over 40% of our gross product in the fourth quarter.

"This was led by the continued growth of [smoke-free division] IQOS, which has now surpassed Marlboro in terms of net revenues.

"We are entering 2024 with strong momentum, and we expect it will be another year of excellent performance underpinned by an acceleration in organic smoke-free net revenue and profit growth."

As at 1430 GMT, shares in PMI were down more than 2%, having lost 3% in pre-market trading.

Share this article

Related Sharecast Articles

Hvivo scores £2.5m contract for Omicron characterisation study
(Sharecast News) - Contract research organisation Hvivo has secured a £2.5m contract with a mid-sized pharmaceutical company to initiate an Omicron characterisation study after the manufacture of its Omicron BA.5 challenge agent was successfully completed in 2023.
MP Evans purchases minority stakes in Indonesian subsidiaries
(Sharecast News) - Palm oil producer MP Evans has purchased a 5% minority holding in the majority of its Indonesian subsidiary trading companies.
JPMorgan upgrades St James's Place, Quilter to 'overweight'
(Sharecast News) - JPMorgan Cazenove upgraded St James's Place and Quilter to 'overweight' from 'neutral' on Monday as it took a look at UK wealth managers.
Shein eyeing potential London listing
(Sharecast News) - Fast fashion retailer Shein will file paperwork for a potential floatation on the London Stock Exchange as soon as this week, according to Sky News, with an initial public offering potentially valuing the firm at roughly £51.7bn.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.